UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 15, 2014

 

 

Dendreon Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35546   22-3203193

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1301 2nd Avenue, Seattle, Washington   98101
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (206) 256-4545

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

Dendreon Corporation (the “Company”) held its 2014 Annual Meeting of Stockholders on May 15, 2014 at the Bridgewater Marriott, 700 Commons Way, Bridgewater, New Jersey 08807. A total of 160,055,271 shares of the Company’s common stock were entitled to vote as of April 2, 2014, the record date for the Annual Meeting, of which 121,494,231 (75.91%) were present in person or by proxy at the Annual Meeting. The votes cast with respect to each item of business properly presented at the meeting are as follows:

The stockholders elected the following nominee to the Company’s Board of Directors to hold office until the 2017 Annual Meeting of Stockholders by a majority of the votes duly cast.

 

    

For

    

Against

    

Abstain

    

Broker Non-

Votes

 

David C. Stump, M.D.

     37,171,034         5,051,421         949,213         78,322,563   

The stockholders approved the amendment to the Dendreon Corporation 2009 Equity Incentive Plan to increase the individual limits and the number of shares authorized for issuance thereunder from 22,200,000 to 32,000,000.

 

For

  

Against

  

Abstain

  

Broker Non-

Votes

32,374,202    10,451,576    345,890    78,322,563

The stockholders recommended against, on a non-binding advisory basis, the approval of the Company’s overall executive compensation program.

 

For

  

Against

  

Abstain

  

Broker Non-

Votes

17,528,195    24,833,870    809,603    78,322,563

The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2014.

 

For

  

Against

  

Abstain

109,878,541    9,590,105    2,025,585

The stockholders approved, on a non-binding advisory basis, the stockholder proposal to repeal the classified board.

 

For

  

Against

  

Abstain

  

Broker Non-

Votes

32,146,853    6,159,199    4,865,616    78,322,563


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      DENDREON CORPORATION
Date: May 21, 2014      

/s/ Robert Crotty

      Robert Crotty
      Vice President, General Counsel and Secretary